American Century Companies’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,728
Closed -$450K 2870
2023
Q1
$450K Sell
3,728
-1,632
-30% -$188K ﹤0.01% 2164
2022
Q4
$617K Buy
5,360
+244
+5% +$26.9K ﹤0.01% 1981
2022
Q3
$525K Hold
5,116
﹤0.01% 1934
2022
Q2
$521K Sell
5,116
-84
-2% -$9.16K ﹤0.01% 1909
2022
Q1
$606K Buy
5,200
+1,727
+50% +$200K ﹤0.01% 1879
2021
Q4
$396K Buy
+3,473
New +$396K ﹤0.01% 2031

Other funds holding BSX.PRA

American Century Companies's BSX.PRA Position: Q2 2023 in Review

American Century Companies sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 3,728 shares — an estimated $450K sold.

American Century Companies first reported a position in BSX.PRA in Q4 2021 and held it in 6 quarters. The position peaked at $617K in Q4 2022. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • American Century Companies reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • American Century Companies sold 3,728 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $450K.
  • American Century Companies first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q4 2021 and held it in 6 quarters.
  • American Century Companies's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $617K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on American Century Companies's 13F filing for Q2 2023, filed 14 Aug 2023.